Long-Term Opioid Therapy for Pain

This Viewpoint discusses recent US Food and Drug Administration data on opioid-related risks and harms; highlights ways in which understanding of these risks and harms remains incomplete; and calls for required postmarketing opioid studies and improved regulatory communications to ensure safer, more effective pain care.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2025-08-27
DOI
https://doi.org/10.1001/jama.2025.13225
Citations
2
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
3.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Opioid Therapy for Pain

Brian T. Bateman, Mark C. Bicket
2 citations
JAMA
Opioid Use Disorder Treatment
3.76
article

Long-Term Opioid Therapy for Pain

Brian T. Bateman, Mark C. Bicket
article en
2 citations

Abstract

This Viewpoint discusses recent US Food and Drug Administration data on opioid-related risks and harms; highlights ways in which understanding of these risks and harms remains incomplete; and calls for required postmarketing opioid studies and improved regulatory communications to ensure safer, more effective pain care.

JAMAVol. 334(12)
University of Michigan (US), VA Center for Clinical Management Research (US), Stanford Medicine (US)
Openalex Percentile: Top 6%
Opioid Use Disorder Treatment
3.76
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.